Reversal effect of Dioscin on multidrug resistance in human hepatoma HepG2/adriamycin cells

European Journal of Pharmacology

Volumn 654, Issue 2, 2011, Pages 129-134

  Sun, Bu Tong ^a,b   Zheng, Li Hua ^a   Bao, Yong Li ^a   Yu, Chun Lei ^a   Wu, Yin ^a   Meng, Xiang Ying ^a   Li, Yu Xin ^a  

^a NORTHEAST NORMAL UNIVERSITY   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

Dioscin; Multidrug resistance; P glycoprotein

Indexed keywords

DIOSCIN; DOXORUBICIN; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 1; SAPONIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER RESISTANCE; CELL STRAIN HEK293; CELL STRAIN HEPG2; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACCUMULATION; DRUG EFFECT; DRUG POTENCY; DRUG POTENTIATION; DRUG SENSITIVITY; EMBRYO; GENE ACTIVITY; HUMAN; HUMAN CELL; IC 50; LIVER CELL CARCINOMA; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; DIOSGENIN; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, MDR; GENETIC VECTORS; HEK293 CELLS; HEP G2 CELLS; HEPATOCYTES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; LIVER NEOPLASMS; P-GLYCOPROTEIN; PLASMIDS; RNA, MESSENGER;

EID: 79551604904     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.12.018     Document Type: Article

References (27)

1. S.V. Ambudkar, C. Kimchi-Sarfaty, Z.E. Sauna, and M.M. Gottesman P-glycoprotein: from genomics to mechanism Oncogene 22 2003 7468 7485
2. W.T. Beck The cell biology of multiple drug resistance Biochem. Pharmacol. 36 1987 2879 2887
3. R.B. Birari, and K.K. Bhutani Pancreatic lipase inhibitors from natural sources: unexplored potential Drug Discov. Today 12 2007 879 889
4. J. Cai, M. Liu, Z. Wang, and Y. Ju Apoptosis induced by dioscin in Hela cells Biol. Pharm. Bull. 25 2002 193 196
5. C. Calatozzolo, M. Gelati, E. Ciusani, F.L. Sciacca, B. Pollo, L. Cajola, C. Marras, and A. Salmaggi Expression of drug resistance proteins P-glycoprotein, MRP1, MRP3, MRP5 and GST-pi in human glioma J. Neurooncol. 74 2005 113 121
6. Editorial Committee of Flora of China Flora of China 1980 Science Publishing Company Beijing
7. T. Fojo, and S. Bates Strategies for reversing drug resistance Oncogene 22 2003 7512 7523
8. J.H. Gerlach, N. Kartner, D.R. Bell, and V. Ling Multidrug resistance Cancer Surv. 5 1986 25 46
9. H. Glavinas, P. Krajcsi, J. Cserepes, and B. Sarkadi The role of ABC transporters in drug resistance, metabolism and toxicity Curr. Drug Deliv. 1 2004 27 42
10. M.M. Gottesman, T. Fojo, and S.E. Bates Multidrug resistance in cancer: role of ATP-dependent transporters J. Nat. Rev. Cancer 2 2002 48 58
11. Y.P. Hu, P. Pourquier, F. Doignon, M. Crouzet, and J. Robert Effects of modulators of multidrug resistance on the expression of the MDR1 gene in human KB cells in culture Anticancer Drugs 7 1996 738 744
12. A. Ivanova, J. Serly, D. Dinchev, I. Ocsovszki, and J. Mdnar Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators In Vivo 23 2009 545 550
13. W.W. Johnson P-glycoprotein-mediated efflux as a major factor in the variance of absorption and distribution of drugs: modulation of chemotherapy resistance Meth. Find. Exp. Clin. Pharmacol. 24 2002 501 514
14. R.P. Keller, H.J. Altermatt, K. Nooter, G. Poschmann, J.A. Laissue, P. Bolling, and P.C. Hiestand SDZ PSC833, a non-immunosuppressive cyclosporine: its potency in overcoming P- glycolprotein-mediated multidrug resistance of murine leukemia Int. J. Cancer 50 1992 593 597
15. Y. Lavie, H.T. Cao, A. Volner, A. Lucci, T.Y. Han, V. Geffen, A.E. Giuliano, and M.C. Cabot Agents that reverse multidrug resistance, tamoxifen, verapamil, andcyclosporinA, block glycosphingolipid metabolism by inhibiting ceramide glycosylation in human cancer cells J. Biol. Chem. 272 1997 1682 1687
16. M. Liscovitch, and Y. Lavie Cancer multidrug resistance: a review of recent drug discovery research IDrugs 5 2002 349 355
17. M.J. Liu, Z. Wang, Y. Ju, J.B. Zhou, Y. Wang, and R.N.-S. Wong The mitotic-arresting and apoptosis-inducing effects of diosgenyl saponins on human leukemia cell lines Biol. Pharm. Bull. 27 2004 1059 1065
18. Q. Mi, D. Lantvit, E. Reyes-Lim, H. Chai, W. Zhao, I.-S. Lee, S. Peraza-Sanchez, O. Ngassapa, L.B. Kardono, S. Riswan, M.G Hollingshead, J.G. Mayo, N.R. Farnsworth, G.A. Cordell, A.D. Kinghorn, and J.M. Pezzuto Evaluation of the potential cancer chemotherapeutic efficacy of natural product isolates employing in vivo hollow fiber tests J. Nat. Prod. 65 2002 842 850
19. V. Ponce de León, and R. Barrera-Rodriguez Changes in P-glycoprotein activity are mediated by the growth of a tumour cell line as multicellular spheroids Cancer Cell Int. 5 2005 20
20. Z. Shi, Y.J. Liang, Z.S. Chen, X.W. Wang, X.H. Wang, Y. Ping, L.M. Chen, X.P. Yang, and L.W. Fu Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo Cancer Biol. Ther. 5 2006 39 47
21. H. Shoji, K. Tsuchida, H. Kishi, N. Yamakawa, T. Matsuzaki, Z. Liu, T. Nakamura, and H. Sugino Identification and characterization of a PDZ protein that interacts with activin type II receptors J. Biol. Chem. 275 2000 5485 5492
22. P. Sweet, P.K. Chan, and L.M. Slater Cyclosporin A and verapamil enhancement of daunorubicin-produced nucleolar protein b23 translocation in daunorubicin-resistant and -sensitive human and murine tumor cells Cancer Res. 49 1989 677 680
23. L.E. Van Vlerken, Z.F. Duan, M.V. Seiden, and M.M. Amiji Modulation of intracellular ceramide using polymeric nanoparticles to overcome multidrug resistance in cancer Cancer Res. 67 2007 4843 4850
24. M.V. Varma, Y. Ashokraj, C.S. Dey, and R. Panchagnula P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement Pharmacol. Res. 48 2003 347 359
25. Z. Wang, J. Zhou, Y. Ju, H. Zhang, M. Liu, and X. Li Effects of two saponins extracted from the polygonatum Zanlanscianense pamp on the human leukemia (HL-60) cells Biol. Pharm. Bull. 24 2001 159 162
26. R.C. Young, R.F. Ozols, and C.E. Myers The anthracycline antineoplastic drugs N. Engl. J. Med. 305 1981 139 153
27. L.H. Zheng, Y.L. Bao, Y. Wu, C.L. Yu, X.Y. Meng, and Y.X. Li Cantharidin reverses multidrug resistance of human hepatoma HepG2/ADRIACIN cells via down-regulation of P-glycoprotein expression Cancer Lett. 272 2008 102 109